Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years
Sponsor: Actio Biosciences, Inc.
Summary
This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.
Official title: A First-in-Human, Phase 1a, Randomized, Double-Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose and Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Administered Orally to Healthy Adults
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2025-08-28
Completion Date
2026-03
Last Updated
2025-11-26
Healthy Volunteers
Yes
Conditions
Interventions
ABS-1230
ABS-1230
Placebo
Placebo
Omeprazole
Omeprazole
Locations (1)
Scientia Clinical Research
Sydney, New South Wales, Australia